Table: Kissei Pharm -2019/20 group results

Kissei Pharmaceutical

12/05/2020 07:00

May 12 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           63.23           72.30          65.50         30.70    
               (-12.5 pct)     (-2.3 pct)     (+3.6 pct)    (-2.7 pct)  
  Operating        1.86            6.20        loss 4.60     loss 1.20  
               (-70.1 pct)     (-37.3 pct)                              
  Recurring        2.43            7.17        loss 3.30   loss 500 mln 
               (-66.1 pct)     (-37.2 pct)                              
  Net
  Net              2.82            5.48           3.10          1.60    
               (-48.6 pct)     (-39.4 pct)    (+10.0 pct)   (-25.6 pct) 
  EPS           60.31 yen      117.33 yen      66.36 yen     34.25 yen  
  Ann Div       52.00 yen       50.00 yen      54.00 yen                
  -Q2 Div       26.00 yen       25.00 yen      27.00 yen                
  -Q4 Div       26.00 yen       25.00 yen      27.00 yen                
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T